Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3-Targeted Single-Domain Antibody PET. [PDF]
Fayn S +17 more
europepmc +1 more source
Novel Imaging Biomarkers for Brain PET Imaging. [PDF]
Landau AM.
europepmc +1 more source
Immunotherapy for Glioblastoma: A Focus on PD-1/PD-L1 Inhibitors. [PDF]
Zoi V +4 more
europepmc +1 more source
The diagnostic value of PET/CT imaging with the Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer [PDF]
core +1 more source
Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancers. [PDF]
Tendler S +18 more
europepmc +1 more source
Evaluation of Tc-Z-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression [PDF]
core +1 more source
Cell surface oncofetal antigens in prostate cancer: therapeutic potential and radioligand targeting. [PDF]
Harbi E +9 more
europepmc +1 more source
Development of Anti-CEA C<sub>H</sub>2 Domain-Deleted Antibody (M5A∆C<sub>H</sub>2) for the PET Imaging of Colorectal Cancer. [PDF]
Jitender J +7 more
europepmc +1 more source
Response Monitoring with [F]FLT PET and Diffusion-Weighted MRI After Cytotoxic 5-FU Treatment in an Experimental Rat Model for Colorectal Liver Metastases [PDF]
core +1 more source

